Stock Rating Upgrade
In the last week the Value Trend Rating for Quest Diagnostics Inc (NYSE: DGX) improved from C to B reflecting improving fundamentals and high Appreciation Potential.
Recent Price Action
Quest Diagnostics Inc (NYSE: DGX) stock closed at $154.38 on 9/13/24 after a slight decline of -0.2%. However, below average trading volume at 67% of normal accompanied the decline. The stock is unchanged during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
DGX is expected to continue to be an important Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Quest Diagnostics has a current Value Trend Rating of B (Positive). This VT Rating improved in recent days from C previously. This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Quest Diagnostics has a neutral Appreciation Score of 51 but a good Power Rating of 76, leading to the Positive Value Trend Rating.
Be the first to comment